Physiological Effects of ANGPTL3 Variants in Humans

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

December 1, 2020

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Hypocholesterolemia
Interventions
OTHER

Kinetics test, oral fat tolerance test, and an oral glucose tolerance test.

Subjects will participate in a kinetics test, oral fat tolerance test, and an oral glucose tolerance test.

Trial Locations (1)

19104

RECRUITING

University of Pennsylvania, Philadelphia

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of Pennsylvania

OTHER

NCT04234724 - Physiological Effects of ANGPTL3 Variants in Humans | Biotech Hunter | Biotech Hunter